Risk of stroke in real-world US individuals with type 2 diabetes receiving semaglutide or a dipeptidyl peptidase 4 inhibitor
Rather than directly suppressing appetite or burning fat, they work through broader metabolic and nutritional pathways
Some individuals may notice reduced appetite or changes in eating patterns during the first few weeks, but meaningful changes on the scale often develop over several weeks or months
In this review, we will discuss currently available glucose-lowering treatments, and patient- and drug-specific factors to consider when selecting glucose-lowering therapy for the treatment of older adults ( 65 years of age) with T2D
Site rotation: Move between abdomen, thighs and upper arms to reduce local irritation and lipohypertrophy [9]
Liu Y, Yin Y, Liu XZ et al (2015) Retrospective analysis of vancomycin nephrotoxicity in elderly Chinese patients